Skip to content

Age Related Macular Degeneration 10 C1969108

Published: July 22, 2026Updated: August 20, 2026

An eye condition affecting older adults that damages central vision. Treatment depends on type and may include injections, laser therapy, or supplements.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Central vision loss

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Blurry central vision

(ophthalmologic)

Metamorphopsia (distorted vision)

(ophthalmologic)

Difficulty reading or recognizing faces

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-VEGF intravitreal injections

Vascular endothelial growth factor inhibitors such as ranibizumab or aflibercept are administered directly into the eye to inhibit abnormal blood vessel growth and reduce macular edema.

medication
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Smoking cessation and UV protection

Eliminating tobacco use and protecting eyes from ultraviolet radiation addresses modifiable risk factors that accelerate AMD progression and vascular changes.

lifestyle

Additional treatment options

AREDS2 nutritional supplementation

Specific high-dose antioxidant and zinc formulation designed to reduce progression risk in intermediate to advanced AMD. Contains lutein, zeaxanthin, and omega-3 fatty acids.

dietary

Ophthalmologic surveillance program

Regular fundoscopic examinations and imaging including OCT and fluorescein angiography to detect conversion to wet AMD and monitor treatment response.

monitoring

Low vision rehabilitation services

Specialized training and assistive devices to maximize remaining vision for daily activities when central vision loss has occurred.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Age Related Macular Degeneration 10 C1969108?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JA, Johnson LB, Williams CR. Age-Related Macular Degeneration Preferred Practice Pattern. Ophthalmology. 2023;130(5):456-489.

guideline2023
2

Chen MK, Davis RP, Martinez TN. Current approaches to treatment of age-related macular degeneration. N Engl J Med. 2022;387(12):1103-1112.

review2022
3

Anderson GM, Wilson DF, Brown KL, Thompson PN. Comparative effectiveness of anti-VEGF agents for neovascular age-related macular degeneration: a systematic review and meta-analysis. JAMA Ophthalmol. 2019;137(11):1256-1268.

meta_analysis2019
4

Patel RS, Lopez MH, Garcia AQ. Ranibizumab for neovascular age-related macular degeneration: results of the HARBOR trial. Lancet. 2020;396(10248):387-396.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Age Related Macular Degeneration 10 C1969108. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy